FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...

Ryzumvi (phentolamine 0.75%) is FDA approved for presbyopia, its second indication after pharmacologically induced mydriasis.

Intensive blood pressure (BP) lowering reduced the risk of major cardiovascular events by 15% for every 10-mm Hg reduction in ...

Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical ...

OneOncology's Larry Bilbrey explains how to guide practices on AI without endorsing products and why technology gaps outweigh ...

The AAO 2026 annual meeting, held in New Orleans, Louisiana, from October 10 to October 12, 2026, was a weekend that provided ...

Older patients with obstructive sleep apnea (OSA) carried a markedly higher burden of cardiometabolic disease and reported ...

For years, pulmonologists treating bronchiectasis had little formal guidance and only off-label tools. That has changed in ...

On the opening day of CHEST 2026 in Phoenix, Arizona, the organization's flagship journal highlights a trio of key papers ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...